Skip to main content
. Author manuscript; available in PMC: 2023 Apr 20.
Published in final edited form as: Med Res Arch. 2023 Jan 31;11(1):10.18103/mra.v11i1.3135. doi: 10.18103/mra.v11i1.3135

Figure 1.

Figure 1.

Timeline of drugs approved by the United States Food and Drug Administration for the management of IBD encompassing ulcerative colitis and Crohn’s disease, and published abstracts and articles for positive phase 2 and 3 clinical trials [163].